Authors
Loading...
Analysis shows megakaryocytic repopulating ability predicts MRD response in younger patients with AML, suggesting chemotherapy effects vary by cell type.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: